Optiver Holding
IPSC icon

Optiver Holding’s Century Therapeutics IPSC Stock Holding History

Optiver Holding’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$902 Buy
368
+336
+1,050% +$768 ﹤0.01% 2517
2026
Q1 		$72 Hold
32
– – ﹤0.01% 2250
2025
Q4 		$32 Hold
32
– – ﹤0.01% 2405
2025
Q3 		$16 Buy
+32
New +$17 ﹤0.01% 2647

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Optiver Holding's IPSC Position: Q2 2026 in Review

Optiver Holding increased its Century Therapeutics (IPSC) stake by 1,050% in Q2 2026, buying an estimated $768 and bringing the position to 368 shares worth $902. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

Optiver Holding first reported a position in IPSC in Q3 2025 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Optiver Holding held 368 shares of Century Therapeutics worth $902 as of Q2 2026.
  • Optiver Holding bought 336 Century Therapeutics shares in Q2 2026, an estimated $768.
  • Century Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2517 holding.
  • Optiver Holding first reported a position in Century Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.